YME1L1 and myocardial infarction: Cardiac-specific ablation of YME1L in mice led to DCM and heart failure; YME1L was also crucial for the progression of experimental autoimmune myocarditis to DCM and the therapeutic efficacy of mesenchymal stem cells in myocardial infarction.